Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: AgAuUSA who wrote (9781)	7/21/1998 9:18:00 AM
From: AgAuUSA	Respond to of 14328

<<I'm the one who quoted the cos statement regarding these convertibles. Remember? I didn't say I liked or agreed with management. I just stated that at this time I no longer have a problem with it. Its done and over.>> The convertible debentures were issued on June 25, 1997. The funds from the placement were utilized to purchase the entire assets of Centocor, UK on July 1, 1997. The Centocor acquisition has been and will be acretive into the future. Centocor was purchased at a discount to the cost of development of their product line, distribution channels and is acretive to future earnings. The arbitrage is likely complete at this time. I'm confident that those who bot the debenture to flip it for the discount are looong gone. This is why I no longer have a problem with the debenture. I believe management has learned a lesson from the experience. The significant insider buying is an indication to me that management will be vested in developing shareholder value. They now own a fairly significant interest in the co. I find that heartening. Hanging tight. Good luck to all.